• Alcohol use disorder
  • Project
  • Research & Development
  • Partners
  • About us
    • About us
    • Board of Directors
    • The Team
    • Scientific Advisers
  • News
Alcohol Use Disorder Alcohol Use Disorder
  • Alcohol use disorder
  • Project
  • Research & Development
  • Partners
  • About us
    • About us
    • Board of Directors
    • The Team
    • Scientific Advisers
  • News

Okategoriserade

Hem » Okategoriserade
 Recruitment ongoing in the phase II study (COMB study).
0

Recruitment ongoing in the phase II study (COMB study).

Recruitment of patients to the phase II study (COMB study) is ongoing at the clinical study site in Gothenburg and in Stockholm. The study team is sharing information about the study including [...]

READ MORE
 Sobrera Pharma AB announces 28 MSEK capital raise through a directed share issue to finance the continued development of SO-001
0

Sobrera Pharma AB announces 28 MSEK capital raise through a directed share issue to finance the continued development of SO-001

Sobrera Pharma AB announces 28 MSEK capital raise through a directed share issue to finance the continued development of SO-001, a new oral therapy for patients with Alcohol Use Disorder (AUD). [...]

READ MORE
Sobrera Pharma AB
  • Erik Dahlbergsgatan 11A
    411 26 Göteborg
  • info@sobrera.com
Latest news & publications
  • We are pleased to welcome Eva Hägglund as Clinical Project Director 14 mars, 2023
  • New Board Member in Sobrera Pharma 11 oktober, 2022
  • SOBRERA PHARMA RECEIVES PATENT APPROVAL IN THE USA 30 juni, 2022
  • Recruitment Ongoing in the Phase II Study (COMB study) 27 januari, 2022
  • Company Update – in Connection with the Annual General Meeting, June 10, 2021 29 juni, 2021
Copyright All Rights Reserved © 2021
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search